The federal Ready, Set, PrEP program ended July 2025. Many websites still list it as active. See what replaced it →

Apretude Cost in 2026: What You'll Actually Pay

Apretude (cabotegravir) is the every-2-month injectable PrEP made by ViiV Healthcare. The list price is roughly $4,000–$5,400 per injection — but most people pay nothing. Here's the full cost breakdown and every pathway to $0.

The Quick Answer

Your Situation What You'll Pay How
Private insurance $0 ACA mandate + ViiV copay savings card
Medicaid $0–$3 Covered under Medicaid drug benefit
Uninsured, income <500% FPL $0 ViiVConnect Patient Assistance Program
Medicare Varies Part D coverage + nonprofit copay funds
No assistance, cash price ~$4,038–$5,460 Per injection (retail pharmacy)

Bottom line: If you have any form of insurance or earn less than roughly $75,000/year, you should be able to get Apretude for $0. The ~$4,000+ list price is what pharmacies charge without any assistance — and almost nobody should be paying that.

Full Cost Breakdown

Apretude's generic name is cabotegravir. It's an intramuscular injection given every 2 months after two initial loading injections one month apart. That means roughly 7 injections per year in the first year and 6 per year after that.

At retail, each injection runs approximately $4,038–$5,460 depending on the pharmacy. That's a potential annual cost of $24,000–$33,000 without any assistance. But this list price is almost entirely irrelevant because of the assistance programs below.

Why is the list price so high?

Apretude is a long-acting injectable — it requires specialized manufacturing and cold-chain storage. ViiV Healthcare (a subsidiary of GSK) is the sole manufacturer with no generic competition yet. The high list price also reflects the pharmaceutical pricing dynamic in which assistance programs effectively make most patients pay $0, while the list price drives insurance reimbursement.

Every Way to Get Apretude for $0

1. ACA Preventive Coverage (Insured Patients)

The Affordable Care Act requires most private insurance plans to cover PrEP — including Apretude — at $0 cost-sharing. This covers the medication itself, required lab work, and clinical visits. Apretude is typically billed under the medical benefit (not pharmacy), since it's administered by a healthcare provider.

Watch out: Some insurers may require prior authorization before approving Apretude, especially since cheaper generic oral PrEP exists. Your provider can handle this — it usually takes a few days to a couple of weeks.

2. ViiV Apretude Savings Program (Insured Patients)

If your insurance leaves you with any out-of-pocket cost, ViiV's copay savings program covers up to $7,850 per year — including both medication costs and injection administration fees. This effectively reduces your copay to $0.

Eligibility: Commercially or privately insured patients. No income requirement. Not available for government insurance (Medicare, Medicaid, TRICARE).

How to enroll: Your provider's office or specialty pharmacy can enroll you, or visit the ViiV program website.

3. ViiVConnect Patient Assistance Program (Uninsured Patients)

If you're uninsured, ViiVConnect provides Apretude completely free to qualifying patients.

Eligibility: Uninsured with household income below 500% of the Federal Poverty Level (~$75,300/year for an individual in 2026). Medicare Part D patients may also qualify under certain criteria.

How to apply: Contact ViiVConnect at 1-844-588-3288 or work with your prescribing provider.

4. Alternate Sites of Care (ASOC) Network

ViiV maintains a network of clinics and providers specifically set up to administer Apretude injections, including for patients who may not have a regular provider. The ASOC network can help connect you with a nearby injection site.

5. Nonprofit Copay Assistance (Medicare Patients)

Medicare beneficiaries can't use manufacturer copay cards, but nonprofit foundations can help:

Patient Advocate Foundation (PAF): Up to $7,500/year for insured patients with income below 400% FPL. PAF and PAN Foundation are merging into a unified "TotalAssist" program launching July 1, 2026.

Good Days Foundation: Up to $7,500/year, primarily for Medicare/military beneficiaries with income below 500% FPL (SSN required).

Apretude vs. Yeztugo: Cost Comparison

Apretude (cabotegravir) Yeztugo (lenacapavir)
Manufacturer ViiV Healthcare (GSK) Gilead Sciences
Dosing Every 2 months Every 6 months
Per injection (list) ~$4,038–$5,460 ~$14,109
Annual list price ~$24,000–$33,000 ~$28,218
Copay program (insured) Up to $7,850/yr Up to $8,000/yr + $100/visit
Free for uninsured? Yes (ViiVConnect, <500% FPL) Yes (Gilead MAP, <500% FPL)
Clinic visits/year 6–7 2 (after initial loading)

Both injectables can be obtained for $0 through their respective manufacturer programs. The practical cost difference comes down to clinic visits — Apretude requires 6–7 per year vs. Yeztugo's 2. If clinic access, time off work, or transportation is a factor, Yeztugo's twice-yearly schedule may save you real money in indirect costs.

For a full head-to-head comparison, see our Yeztugo vs. Apretude guide.

How to Start Apretude

1

Talk to a provider

Discuss injectable PrEP with your doctor, an HIV specialist, or a provider at an FQHC. You'll need baseline labs: HIV test, kidney function, hepatitis B screening, and STI testing.

2

Sort out coverage

If insured, confirm Apretude coverage with your plan (it may need prior authorization). Ask your provider to enroll you in the ViiV copay savings program. If uninsured, apply through ViiVConnect at 1-844-588-3288.

3

Loading phase

Your first two injections are given one month apart. After that, you'll return every 2 months. Each injection appointment takes about 15–20 minutes.

4

Ongoing care

You'll get an HIV test before each injection and periodic lab work. All of this is covered at $0 under the ACA for insured patients.

Prefer a daily pill instead?

Oral PrEP (generic TDF/FTC or Descovy) is also free through telehealth platforms. MISTR handles everything — consultation, labs, and medication delivery — at $0 in all 50 states.

Start Free PrEP with MISTR →

Use referral code ANDR735 at signup. Using this code helps keep FreePrEP.org running and supports free PrEP access for everyone.

Frequently Asked Questions

Is cabotegravir the same as Apretude?
Yes. Cabotegravir is the generic (active ingredient) name. Apretude is ViiV Healthcare's brand name for injectable cabotegravir used for PrEP. When people search for "cabotegravir cost," they're looking for Apretude pricing.
Does Apretude require prior authorization?
Often, yes. Many insurers require prior authorization for Apretude since cheaper oral PrEP alternatives exist. Your provider handles this process. It typically takes a few days to 2–4 weeks for approval. Under the ACA, if your insurer denies Apretude but your provider determines oral PrEP is medically inappropriate for you, the insurer must have an expedited exceptions process.
Can I get Apretude through a telehealth platform like MISTR?
Not directly. Apretude is an injection that must be administered by a healthcare provider in person. Telehealth platforms like MISTR currently provide oral PrEP only. For injectable PrEP, you'll need an in-person provider — your doctor, an FQHC, or a clinic in ViiV's ASOC network. See our injectable PrEP guide for details on finding a provider.
Is there a generic version of Apretude?
No. As of May 2026, there is no generic injectable cabotegravir available in the United States. ViiV Healthcare holds the patent, and no generic competition is expected in the near term. However, ViiV's assistance programs mean most people pay $0 regardless.
Can I switch from Apretude to Yeztugo?
Yes. You can switch from Apretude (cabotegravir) to Yeztugo (lenacapavir), though the transition should be managed by your healthcare provider. Yeztugo has its own loading phase (oral doses plus an initial injection), and your provider will time the transition to ensure continuous protection. See our Yeztugo vs. Apretude comparison for more details on switching.
Does Medicare cover Apretude?
Medicare Part D plans generally cover Apretude, but copays can be significant. Manufacturer copay cards are not available for government-insured patients. However, ViiVConnect's PAP may cover eligible Medicare patients, and nonprofit foundations (PAF, Good Days) can help with remaining costs. Contact ViiV at 1-844-588-3288 to check your eligibility.

Related Guides

Pricing data sourced from GoodRx, SingleCare, ViiV Healthcare, and manufacturer program materials. FreePrEP.org is an independent resource — not affiliated with any government agency or pharmaceutical company. Full disclosure